BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32959241)

  • 1. Alphavirus-Based Antigen Preparation.
    Lundstrom K
    Methods Mol Biol; 2021; 2183():63-81. PubMed ID: 32959241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alphavirus-Based Vaccines.
    Lundstrom K
    Methods Mol Biol; 2016; 1404():313-328. PubMed ID: 27076308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a Plasmid DNA-Based Alphavirus Vaccine on Immunization Efficiency.
    Lundstrom K
    Methods Mol Biol; 2021; 2197():33-47. PubMed ID: 32827131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alphavirus-based vaccines.
    Lundstrom K
    Viruses; 2014 Jun; 6(6):2392-415. PubMed ID: 24937089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alphavirus-Based Vaccines.
    Lundstrom K
    Methods Mol Biol; 2017; 1581():225-242. PubMed ID: 28374252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-viral amplification systems for gene transfer: vectors based on alphaviruses.
    Smerdou C; Liljeström P
    Curr Opin Mol Ther; 1999 Apr; 1(2):244-51. PubMed ID: 11715947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alphavirus DNA and particle replicons for vaccines and gene therapy.
    Polo JM; Gardner JP; Ji Y; Belli BA; Driver DA; Sherrill S; Perri S; Liu MA; Dubensky TW
    Dev Biol (Basel); 2000; 104():181-5. PubMed ID: 11713818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.
    Dupuy LC; Richards MJ; Livingston BD; Hannaman D; Schmaljohn CS
    J Immunol Res; 2018; 2018():8521060. PubMed ID: 29967804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors.
    Leitner WW; Ying H; Driver DA; Dubensky TW; Restifo NP
    Cancer Res; 2000 Jan; 60(1):51-5. PubMed ID: 10646851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alphavirus vectors: development and potential therapeutic applications.
    Schlesinger S
    Expert Opin Biol Ther; 2001 Mar; 1(2):177-91. PubMed ID: 11727528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
    Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
    J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.
    Wang M; Jokinen J; Tretyakova I; Pushko P; Lukashevich IS
    Vaccine; 2018 Jan; 36(5):683-690. PubMed ID: 29287681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alphavirus vectors for cancer gene therapy (review).
    Yamanaka R
    Int J Oncol; 2004 Apr; 24(4):919-23. PubMed ID: 15010830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology and application of alphaviruses in gene therapy.
    Lundstrom K
    Gene Ther; 2005 Oct; 12 Suppl 1():S92-7. PubMed ID: 16231060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Alphaviral Vectors for Immunomodulation in Cancer Therapy.
    Zajakina A; Spunde K; Lundstrom K
    Curr Pharm Des; 2017; 23(32):4906-4932. PubMed ID: 28641531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid DNA-based Alphavirus Vaccines.
    Lundstrom K
    Vaccines (Basel); 2019 Mar; 7(1):. PubMed ID: 30857255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations.
    Knudsen ML; Ljungberg K; Kakoulidou M; Kostic L; Hallengärd D; García-Arriaza J; Merits A; Esteban M; Liljeström P
    J Virol; 2014 Nov; 88(21):12438-51. PubMed ID: 25122792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alphavirus-based vaccines.
    Lundstrom K
    Curr Opin Mol Ther; 2002 Feb; 4(1):28-34. PubMed ID: 11883692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
    Pushko P; Geisbert J; Parker M; Jahrling P; Smith J
    J Virol; 2001 Dec; 75(23):11677-85. PubMed ID: 11689649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.